Statutory Rules
1973 No.
REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1973.*
WHEREAS it is provided by sub-section 101 (4) of the National Health Act 1953-1973 that a drug or medicinal preparation that was not a pharmaceutical benefit under the National Health Act 1953-1958 immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:
AND WHEREAS that Committee has recommended to the Minister that the following drugs and medicinal preparations be prescribed as pharmaceutical benefits under section 85 of the National Health Act 1953-1973, namely, the drugs and medicinal preparations specified in the Third Schedule to the National Health (Pharmaceutical Benefits) Regulations, as amended by the following Regulations, that had not previously been prescribed as pharmaceutical benefits:
NOW THEREFORE I, THE GOVERNOR-GENERAL of Australia, acting with the advice of the Executive Council, hereby make the following Regulations under the National Health Act 1953-1973.
Dated this nineteenth day of July, 1973.
Paul Hasluck
Governor-General.
By His Excellency’s Command,
Minister of State for Health.
__________
Amendments of the National Health (Pharmaceutical Benefits) Regulations†
Commencement.
1. These Regulations shall come into operation on 1st August, 1973.
_______________________________________________________________________________
* Notified in the Commonwealth Gazette on 1973.
† Statutory Rules 1959 No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 107; 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; 1964, Nos. 12, 57 and 135; 1965, Nos. 51, 151 and 152; 1966, Nos. 80 and 144; 1967, Nos. 67, 116 and 153; 1968, Nos. 44, 76, 88 and 146; 1969, Nos. 44, 107 and 185; 1970, Nos. 39, 94, 119 and 186; 1971, Nos. 44, 101, 136 and 154; 1972, Nos. 32, 121 and 205; and 1973, Nos. 15 and 57.
14802/73—Price 35c 9/21.6.1973
First, Second, Third, Fourth and Fifth Schedules.
2. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules substituted:—
FIRST SCHEDULE Regulation 10
Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as or, except as specially provided, used in Pharmaceutical Benefits
1. Acetarsol
2. Acetomenaphthone
3. Acetomenaphthone Tablets
4. Acetrizoic Acid
5. Alcohol Dehydrated
6. Alcohol (95%)
7. Allopurinol
8. Almond Oil
9. Aloes
10. Alprenolol Hydrochloride
11. Aluminium Hydroxide Tablets
12. Amethocaine Hydrochloride
13. Amitriptyline Injection
14. Amodiaquine Tablets
15. Amphetamine Sulphate
16. Amphetamine Sulphate Tablets
17. Amylobarbitone Sodium Tablets
18. Antazoline Hydrochloride
19. Antazoline Tablets
20. Antimony Sodium Tartrate
21. Antimony Sodium Tartrate Injection
22. Apomorphine Hydrochloride
23. Apomorphine Injection
24. Arachis Oil
25. Aspirin Phenacetin and Codeine Tablets
26. Aspirin Phenacetin and Codeine Tablets Soluble
27. Azathioprine
28. Bacillus Calmette-Guerin Vaccine
29. Barium Sulphate
30. Beclomethasone Dipropionate
31. Belladonna Herb
32. Belladonna Herb, Powdered
33. Bemegride
34. Bemegride Injection
35. Bendrofluazide
36. Benzhexol Hydrochloride
37. Benzyl Alcohol
38. Betamethasone Sodium Phosphate Tablets
39. Bethanidine Sulphate
40. Bisacodyl
41. Bisacodyl Suppositories
42. Bisacodyl Tablets
43. Botulinum Antitoxin
44. Bupivacaine Hydrochloride
45. Busulphan
46. Eutobarbitone
47. Butylated Hydroxyanisole
48. Butylated Hydroxytoluene
49. Caffeine Hydrate
50. Calciferol Solution
51. Calcium Cyclamate
52. Camphor
53. Caramiphen Hydrochloride
54. Caramiphen Tablets
55. Caraway
56. Carbamazepine
57. Carbimazole
58. Carbon Dioxide
59. Carbromal
60. Carbromal Tablets
61. Cardamom Fruit
62. Cascara
63. Castor Oil
64. Catgut, Sterilised, Surgical
65. Cellulose, Oxidised
66. Cetylpyridinium Chloride
67. Chlorambucil
68. Chlorcyclizine Hydrochloride
69. Chlordiazepoxide Capsules
70. Chlordiazepoxide Hydrochloride
71. Chlorhexidine Gluconate Solution
72. Chlorhexidine Hydrochloride
73. Chloroform
74. Chlormadinone Acetate
75. Chlormerodrin (107Hg) Injection
76. Chloroquine Phosphate
77. Chloroquine Phosphate Injection
78. Chloroquine Sulphate
79. Chlorothiazide
80. Chlorotrianisene
81. Chlorotrianisene Capsules
82. Chlorphenesin
83. Chlorproguanil Hydrochloride
84. Chlorproguanil Tablets
85. Chlorpropamide
86. Chlorthalidone
87. Cholera Vaccine Mixed
88. Choline-Theophyllinate Tablets
89. Cinchocaine Hydrochloride
90. Cinnamon
91. Clofibrate
92. Cochineal
93. Colchicine
94. Colchicum Corm
95. Colchicum Liquid Extract
96. Colchicum Tincture
97. Colistin Tablets
98. Colophony
99. Concentrated Peppermint Water
100. Coriander
101. Coriander Oil
102. Corticotrophin
103. Corticotrophin Injection
104. Corticotrophin Gelatin Injection
105. Corticotrophin Zinc Hydroxide Injection
106. Cortisone Acetate
107. Cottonseed Oil
108. Cresol
109. Cresol and Soap Solution
110. Crotamiton
111. Cyanocobalamin
112. Cyanocobalamin (57Co)
113. Cyanocobalamin (58Co)
114. Cyclamic Acid
115. Cyclizine Tablets
116. Cyclobarbitone Calcium
117. Cyclomethycaine Sulphate
118. Cyclopenthiazide
119. Cyclopentolate Hydrochloride
120. Cyclopropane
121. Cycloserine
122. Cycloserine Tablets
123. Dapsone
124. Deoxycortone Acetate
First Schedule—continued
125. Deoxycortone Acetate Implants
126. Deoxycortone Acetate Injection
127. Dequalinium Acetate
128. Dequalinium Chloride
129. Desipramine Hydrochloride
130. Dexamphetamine Sulphate
131. Dexamphetamine Tablets
132. Dextran 110 Injection
133. Dextromethorphan Hydrobromide
134. Dextromethorphan Tablets
135. Dextropropoxyphene Capsules
136. Dextropropoxyphene Hydrochloride
137. Dextropropoxyphene Napsylate
138. Dextrose Monohydrate
139. Diamorphine Hydrochloride
140. Diamorphine Injection
141. Diazepam Capsules
142. Dibromopropamidine Isethionate
143. Dichloralphenazone
144. Dichlorophen
145. Dichlorophen Tablets
146. Dichlorphenamide
147. Diethylcarbamazine Citrate
148. Diethylcarbamazine Tablets
149. Digitalis Leaf
150. Digitalis Prepared
151. Digitoxin
152. Digitoxin Tablets
153. Dihydrocodeine Injection
154. Dihydrocodeine Tablets
155. Di-iodohydroxyquinoline Tablets
156. Diloxanide Furoate
157. Dilute Alcohols
158. Dimenhydrinate
159. Dimenhydrinate Injection
160. Dimenhydrinate Tablets
161. Dimercaprol
162. Dimethisterone Tablets
163. Diodone Injection
164. Diphenoxylate Hydrochloride
165. Diphtheria and Pertussis Vaccine
166. Diphtheria, Tetanus and Poliomyelitis Vaccine
167. Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine
168. Dipipanone Hydrochloride.
169. Dipipanone Injection
170. Dodecyl Gallate
171. Domiphen Bromide
172. Dried Human Albumin
173. Dusting Powder Absorbable
174. Dydrogesterone
175. Dydrogesterone Tablets
176. Edrophonium Chloride
177. Edrophonium Injection
178. Eltor Vaccine
179. Emetine and Bismuth Iodide
180. Emetine Hydrochloride
181. Erythromycin
182. Ethacrynic Acid
183. Ethchlorvynol
184. Ether Anaesthetic
185. Ether Solvent
186. Ethionamide
187. Ethionamide Tablets
188. Ethisterone
189. Ethisterone Tablets
190. Ethopropazine Hydrochloride
191. Ethotoin
192. Ethyl Chloride
193. Ethyl Oleate
194. Ethylene-diamine Hydrate
195. Eucalyptus Oil
196. Eugenol
197. Ferric Citrate (59Fe) Injection
198. Ferrous Fumarate
199. Ferrous Succinate Tablets
200. Fludrocortisone Acetate
201. Fluoxymesterone
202. Gallamine Triethiodide
203. Gallamine Injection
204. Gamma Benzene Hexachloride
205. Gelatin Sponge, Absorbable
206. Gentian
207. Gentian Tincture, Compound
208. Ginger
209. Gold (198Au) Injection
210. Guanethidine Sulphate
211. Halothane
212. Helium
213. Heparin
214. Hexachlorophane
215. Hexylresorcinol
216. Histamine Acid Phosphate
217. Histamine Acid Phosphate Injection
218. Human Albumin
219. Human Antihaemophilic Fraction
220. Human Blood, Whole
221. Human Fibrin Foam
222. Human Fibrinogen
223. Human Normal Gamma Globulin Injection
224. Human Plasma, Dried
225. Human Plasma Protein Fraction
226. Human Plasma Protein Fraction, Dried
227. Human Red Blood Corpuscles, Concentrated
228. Human Serum, Dried
229. Human Thrombin
230. Hydrochlorothiazide
231. Hydrocortisone Hydrogen Succinate
232. Hydroflumethiazide
233. Hydrogen Peroxide Solution, Strong
234. Hydroxocobalamin
235. Hydroxychloroquine Sulphate
236. Hydroxyprogesterone Hexanoate
237. Hyoscine Injection
238. Hyoscine Eye Ointment
239. Hyoscine Tablets
240. Hyoscyamus
241. Hyoscyamus Dry Extract
242. Indigo Carmine
243. Indomethacin
244. Influenza Vaccine
245. Industrial Methylated Spirit
246. Inulin
247. Inulin Injection
248. Iodinated (125I) Human Serum Albumin Injection
249. Iodinated (131I) Human Serum Albumin Injection
250. Iodipamide Meglumine Injection
251. Iodised Oil Fluid Injection
252. Iopanoic Acid
253. Iopanoic Acid Tablets
254. Iophendylate Injection
255. Iothalamic Acid
256. Ipecacuanha, Prepared
257. Isocarboxazid
258. Isocarboxazid Tablets
First Schedule—continued
259. Isoniazid
260. Isopropyl Alcohol
261. Kaolin, Heavy
262. Laevulose
263. Lemon Peel, Dried
264. Levallorphan Injection
265. Levodopa
266. Levorphanol Injection
267. Levorphanol Tablets
268. Levorphanol Tartrate
269. Lignocaine and Adrenaline Injection
270. Liothyronine Sodium
271. Liquorice
272. Lithium Carbonate
273. Lucanthone Hydrochloride
274. Lucanthone Tablets
275. Magnesium Stearate
276. Maize Oil
277. Male Fern
278. Male Fern Extract
279. Maleic Acid
280. Measles Vaccine (Inactivated)
281. Measles Vaccine (Live Attenuated)
282. Mecamylamine Hydrochloride
283. Mefenamic Acid
284. Mefenamic Acid Capsules
285. Meglumine Iothalamate Injection
286. Melarsoprol
287. Melarsoprol Injection
288. Melphalan
289. Melphalan Injection
290. Mepacrine Hydrochloride
291. Mephentermine Sulphate
292. Meprobamate
293. Meprobamate Tablets
294. Mepyramine Injection
295. Mepyramine Maleate
296. Mepyramine Tablets
297. Mercaptopurine
298. Mersalyl Acid
299. Metaraminol Tartrate
300. Methadone Hydrochloride
301. Methandienone
302. Methicillin Sodium
303. Methohexitone Injection
304. Methoin
305. Methoserpidine
306. Methoserpidine Tablets
307. Methoxyflurane
308. Methylcellulose 450
309. Methyl Hydroxybenzoate
310. Methylamphetamine Hydrochloride
311. Methylamphetamine Injection
312. Methylamphetamine Tablets
313. Methyldopa
314. Methylergometrine Maleate
315. Methylprednisolone Tablets
316. Methylthiouracil
317. Methylthiouracil Tablets
318. Methyprylone
319. Methyprylone Tablets
320. Metronidazole
321. Metyrapone
322. Morphine Sulphate Tablets
323. Nalorphine Hydrobromide
324. Nandrolone Decanoate
325. Nandrolone Phenylpropionate
326. Naphazoline Hydrochloride
327. Nealbarbitone
328. Nealbarbitone Tablets
329. Neostigmine Bromide
330. Nialamide
331. Nialamide Tablets
332. Niclosamide
333. Nicotinic Acid
334. Nicoumalone
335. Nikethamide
336. Nikethamide Injection
337. Nitrazepam
338. Nitrous Oxide
339. Norethandrolone
340. Norethandrolone Tablets
341. Noscapine
342. Novobiocin Calcium
343. Novobiocin Sodium
344. Novobiocin Tablets
345. Nux Vomica
346. Octyl Gallate
347. Oestradiol Benzoate
348. Oestradiol Benzoate Injection
349. Olive Oil
350. Opium
351. Opium, Powdered
352. Orange Peel, Dried Bitter
353. Orphenadrine Hydrochloride
354. Oxygen
355. Oxyphenbutazone
356. Oxyphenbutazone Tablets
357. Oxyphencyclimine Hydrochloride
358. Oxytetracycline Tablets
359. Oxytocin Tablets
360. Paramethadione
361. Paromomycin Capsules
362. Paromomycin Sulphate
363. Pempidine Tartrate
364. Penicillamine
365. Penicillamine Hydrochloride
366. Pentagastrin
367. Pentagastrin Injection
368. Pentamidine Isethionate
369. Pentamidine Injection
370. Pentolinium Tartrate Tablets
371. Peppermint Oil
372. Percutaneous Bacillus Calmette-
Guerin Vaccine
373. Perphenazine
374. Perphenazine Tablets
375. Pethidine Tablets
376. Phenacetin
377. Phenazocine Hydrobromide
378. Phenazocine Injection
379. Phenazocine Tablets
380. Phenelzine Sulphate
381. Phenelzine Tablets
382. Phenindamine Tartrate
383. Phenindione
384. Phenmetrazine Hydrochloride
385. Phenmetrazine Tablets
386. Phenolphthalein Tablets
387. Phenolsulphonphthalein
388. Phenoxybenzamine Capsules
389. Phenoxybenzamine Hydrochloride
390. Phenoxymethylpenicillin
391. Phenoxymethylpenicillin Potassium
392. Phentolamine Mesylate
393. Phentolamine Injection
394. Phenylephrine Injection
395. Phosphoric Acid
396. Phytomenadione Capsules
397. Phytomenadione Tablets
First Schedule—continued
398. Piperazine Citrate
399. Piperazine Phosphate Tablets
400. Poldine Methylsulphate
401. Poldine Tablets
402. Poliomyelitis Vaccine (Inactivated)
403. Poliomyelitis Vaccine (Oral)
404. Potassium Bromide
405. Potassium Chloride Injection
406. Potassium Hydroxide
407. Potassium Nitrate
408. Prednisolone Pivalate
409. Prednisolone Pivalate Injection
410. Prednisone Acetate
411. Primaquine Phosphate
412. Probenecid
413. Procainamide Tablets
414. Procaine and Adrenaline Injection
415. Prochlorperazine Maleate
416. Prochlorperazine Mesylate
417. Procyclidine Hydrochloride
418. Progesterone
419. Progesterone Injection
420. Proguanil Hydrochloride
421. Promazine Hydrochloride
422. Promazine Injection
423. Promazine Tablets
424. Promethazine Theoclate
425. Propranolol Hydrochloride
426. Propyl Gallate
427. Propyliodone
428. Propyliodone Injection
429. Propyliodone Oily Injection
430. Propylthiouracil
431. Pyrazinamide
432. Pyridostigmine Bromide
433. Pyrimethamine
434. Pyroxylin
435. Quillaia
436. Quinine Dihydrochloride
437. Quinine Dihydrochloride Injection
438. Rabies Antiserum
439. Rabies Vaccine
440. Rubella Vaccine (Live Attenuated)
441. Senna Fruit
442. Sesame Oil
443. Silver Nitrate, Toughened
444. Slow Lithium Carbonate Tablets
445. Slow Orphenadrine Citrate Tablets
446. Soda Lime
447. Sodium Acetrizoate Injection
448. Sodium Antimonylgluconate
449. Sodium Antimonylgluconate Injection
450. Sodium Aurothiomalate
451. Sodium Bicarbonate Compound Tablets
452. Sodium Bromide
453. Sodium Calciumedetate
454. Sodium Chromate (51Cr) Solution
455. Sodium Citrate Tablets
456. Sodium Cyclamate
457. Sodium Diatrizoate
458. Sodium Diatrizoate Injection
459. Sodium Fluoride
460. Sodium Fusidate Capsules
461. Sodium Hydroxide
462. Sodium Iodide (131I) Injection
463. Sodium Iodide (125I) Solution
464. Sodium Iodide (131I) Solution
465. Sodium Iodohippurate (131I) Injection
466. Sodium Iothalamate Injection
467. Sodium Lauryl Sulphate
468. Sodium Phosphate (32P) Injection
469. Sodium Stibogluconate
470. Sodium Stibogluconate Injection
471. Solapsone
472. Solapsone Tablets
473. Sorbitol Injection
474. Spironolactone
475. Staphylococcus Antitoxin
476. Stibophen
477. Stibophen Injection
478. Stramonium
479. Sulphadiazine Sodium
480. Sulphadimethoxine
481. Sulphadimidine Injection
482. Sulphadimidine Sodium
483. Sulphamethizole
484. Sulphamethoxydiazine
485. Sulphamethoxypyridazine
486. Sulphapyridine
487. Sulphinpyrazone
488. Sulphobromophthalein Sodium
489. Sulphomyxin Injection
490. Sulphomyxin Sodium
491. Sulthiame
492. Suramin
493. Suramin Injection
494. Suxamethonium Chloride
495. Suxamethonium Bromide
496. Suxamethonium Chloride Injection
497. Testosterone
498. Testosterone Phenylpropionate Injection
499. Tetanus and Pertussis Vaccine
500. Tetanus Vaccine (Alum Precipitated)
501. Tetanus Vaccine (Precipitated Toxoid
Aluminium Hydroxide)
502. Tetanus Vaccine (Simple Solution)
503. Tetrachloroethylene
504. Tetrachloroethylene Capsules
505. Tetracycline Tablets
506. Thiambutosine
507. Thiomersal
508. Thiopentone Sodium
509. Thiopentone Injection
510. Thioridazine Hydrochloride
511. Thyroid
512. Thyroxine Sodium
513. Tolnaftate
514. Tolazoline Hydrochloride
515. Tolazoline Tablets
516. Tolbutamide
517. Tolu Balsam
518. Tranylcypromine Sulphate
519. Tranylcypromine Tablets
520. Triamterene Capsules
521. Trichloroethylene
522. Tricyclamol Chloride
523. Tricyclamol Tablets
524. Trimipramine Maleate
525. Tryparsamide
526. Tryparsamide Injection
527. Tuberculin, Old
528. Tuberculin Purified Protein Derivative
529. Tubocurarine Chloride
530. Tubocurarine Injection
531. Turpentine Oil
532. Typhoid-Paratyphoid A and B
533. Typhoid-Paratyphoid A and B and
Cholera Vaccine
First Schedule—continued
534. Typhoid-Paratyphoid A and B and
Tetanus Vaccine
535. Typhoid-Paratyphoid A, B and C
Vaccine
536. Undecenoic Acid
537. Urea
538. Urea Injection
539. Vancomycin Hydrochloride
540. Vancomycin Injection
541. Vinyl Ether
542. Vitamin A Ester Concentrate
543. Yellow Fever Vaccine
544. Zinc Undecenoate
545. Zinc Undecenoate Ointment
‑‑‑‑‑‑‑‑‑‑‑
SECOND SCHEDULE Regulation 10 (3)
Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
1 | Acepifylline......... | — |
2 | Acetylsulphafurazole... | — |
3 | Acetylcysteine....... | — |
4 | Acrylic Resin........ | — |
5 | Adrenaline Hydrochloride | — |
6 | Albumaid XP........ | — |
7 | Alginic Acid Compound. | — |
8 | Aluminium Sodium Silicate | — |
9 | Amino Acids........ | Amino Acids with Sorbitol |
|
| Amino Acids with Sorbitol and Alcohol |
10 | Aminocaproic Acid.... | — |
11 | Aminogran.......... | — |
12 | Amphotericin B | Tetracycline, B.P.C., with buffering agent and Amphotericin B |
13 | Ampicillin.......... | — |
14 | Ampicillin Trihydrate... | Purified Water, B.P., with Ampicillin Trihydrate |
15 | Antazoline Sulphate.... | Naphazoline Nitrate with Antazoline Sulphate |
16 | Ascorbic Acid........ | Vitamin A with Thiamine Hydrochloride, Riboflavine Nicotinamide, Vitamin D and Ascorbic Acid |
|
| Ferrous Sulphate mixture and Ferrous Sulphate mixture C.F. of the Australian Pharmaceutical Formulary |
|
| Ferrous Sulphate mixture Prescribers’ List |
|
| Ferrous Sulphate mixture Prescribers’ List Children’s Section |
17 | Attapulgite.......... | Dihydrostreptomycin Sulphate with Pectin, Dried Aluminium Hydroxide Gel and Attapulgite |
18 | Bacitracin.......... | Neomycin Sulphate with Polymyxin B Sulphate and Bacitracin |
19 | Bacitracin Zinc....... | Neomycin Undecenoate with Bacitracin Zinc |
|
| Polymyxin B Sulphate with Neomycin Sulphate and Bacitracin Zinc |
20 | “ BANISH ”......... | — |
21 | Belladonna Herb, Prepared | Phenobarbitone with Belladonna Herb, Prepared |
22 | Belladonna, Dry Extract . | Phenolphthalein with Aloin, Strychnine, B.P.C. 1959, Ipecacuanha and Dry Extract of Belladonna |
23 | Betamethasone....... | Betamethasone Acetate with Betamethasone |
24 | Betamethasone Acetate . | Betamethasone with Betamethasone Acetate |
25 | Betamethasone Sodium Phosphate | — |
26 | Betamethasone Phosphate | — |
27 | Brompheniramine Maleate | — |
28 | Calciferol........... | — |
29 | Calcium Di-Oxytetracycline | — |
30 | Calcium Lactate-Gluconate | Calcium Carbonate, B.P., with Calcium Lactate-Gluconate |
31 | Capsicum Oleoresin.... | Cascara Dry Extract with Phenolphthalein, Sodium Tauroglycocholate, B.P.C. 1954, and Capsicum Olcoresin |
32 | Carbachol.......... | Hypromellose 4500 with Carbachol |
33 | Carbinoxamine Maleate . | — |
34 | Cascara Dry Extract.... | Phenolphthalein with Capsicum Oleoresin, Sodium Tauroglycocholate, B.P.C. 1954, and Cascara Dry Extract |
35 | Ceratonia, B.P.C. 1949.. | — |
36 | Chloramine, B.P.C. | — |
37 | Chloramphenicol...... | Polymyxin B Sulphate with Chloramphenicol |
38 | Chloramphenicol Palmitate, B.P.C. | — |
39 | Chloramphenicol Stearate | — |
40 | Chlorhexidine Gluconate | — |
41 | Chlorpheniramine Maleate | — |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
42 | Chlorpromazine Hydro-chloride | — |
43 | Choline Theophyllinate.. | Guaiphenesin with Choline Theophyllinate |
44 | Clemastine Hydrogen Fumarate | — |
45 | Clemizole Tannate..... | — |
46 | Cloxacillin Sodium.... | Purified Water, B.P., with Cloxacillin Sodium |
47 | Colistin Sulphate...... | Neomycin Sulphate with Colistin Sulphate |
48 | Cortisone Acetate..... | — |
49 | Cyclizine Hydrochloride | Ergotamine; Tartrate with Caffeine and Cyclizine Hydrochloride |
50 | Cymogran.......... | — |
51 | Cyproheptadine Hydrochloride | — |
52 | Danthron........... | Dioctyl Sodium Sulphosuccinate B.P.C., with Danthron |
53 | Demecarium Bromide... | — |
54 | Demethylchlortetracycline Hydrochloride | Nystatin with Demethylchlortetracycline Hydrochloride |
55 | Dexamethasone....... | Framycetin Sulphate with Gramicidin and Dexamethasone |
56 | Dexamethasone Metasulphobenzoate | Framycetin Sulphate with Gramicidin and Dexamethasone Metasulphobenzoate |
57 | Dexchlorpheniramine Maleate | — |
58 | Dextrans........... | Dextrose with Dextrans |
|
| Sodium Chloride with Dextrans |
59 | Dextrose Polymer | — |
60 | Diazepam........... | — |
61 | Dichloralphenazon .... | — |
62 | Dicyclomine Hydrochloride | Doxylamine Succinate with Pyridoxine Hydrochloride and Dicyclomine Hydrochloride |
63 | Dienoestrol.......... | — |
64 | Diethanolamine Fusidate | — |
65 | Digoxin............ | — |
66 | Dihydrocodeine Tartrate | — |
67 | Dihydrostreptomycin Sulphate, B.P. 1958 | Attapulgite with Pectin, Dried Aluminium Hydroxide Gel and Dihydrostreptomycin Sulphate, B.P. 1958 |
|
| Kaolin with Pectin, Aluminium Hydroxide Get and Dihydrostreptomycin Sulphate, B.P. 1958 |
68 | Dihydrotachysterol.... | — |
69 | Dimethicone, B.P.C..... | — |
70 | Dimethisterone ....... | Ethinyloestradiol with Dimethisterone |
71 | Dioctyl Sodium Sulphosuccinate, B.P.C. | Danthron with Dioctyl Sodium Sulphosuccinate, B.P.C. |
72 | Diphenhydramine Hydrochloride | Ergotamine Tartrate with Caffeine Citrate and Diphenhydramine Hydrochloride |
73 | Diphenylpyraline Hydrochloride | — |
74 | Diphtheria Vaccine.... | Diphtheria and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed) |
|
| Diphtheria, Tetanus (Purified Toxoid Aluminium Phosphate Adsorbed) and Pertussis Vaccine |
75 | Doxycycline Hydrochloride | — |
76 | Doxylamine Succinate .. | Dicyclomine Hydrochloride with Pyridoxine Hydrochloride and Doxylamine Succinate |
77 | Ecothiopate Iodide..... | — |
78 | Ergometrine Maleate... | Oxytocin with Ergometrine Maleate |
79 | Ergotamine Tartrate.... | Caffeine with Ergotamine Tartrate |
|
| Caffeine with Cyclizine Hydrochloride and Ergotamine Tartrate |
|
| Caffeine Citrate with Diphenhydramine Hydrochloride and Ergotamine Tartrate |
|
| Caffeine with Meclozine Hydrochloride and Ergotamine Tartrate |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
80 | Erythromycin Estolate... | — |
81 | Erythromycin Stearate... | — |
82 | Ethinyloestradiol...... | Dimethisterone with Ethinyloestradiol |
|
| Ethynodiol Diacetate with Ethinyloestradiol |
|
| Megestrol Acetate with Ethinyloestradiol |
|
| Norethisterone Acetate with Ethinyloestradiol |
|
| Norgestrel with Ethinyloestradiol |
83 | Ethosuximide......... | — |
84 | Ethynodiol Diacetate.... | Ethinyloestradiol with Ethynodiol Diacetate |
|
| Mestranol with Ethynodiol Diacetate |
85 | Ferric Hydroxide...... | — |
86 | Ferrous Aminoacetosulphate | — |
87 | Ferrous Succinate...... | — |
88 | Fluclorolone Acetonide .. | — |
89 | Fluocinolone Acetonide.. | — |
90 | Fluocortolone Hexanoate . | Fluocortolone Pivalate with Fluocortolone Hexanoate |
91 | Fluocortolone Pivalate... | Fluocortolone Hexanoate with Fluocortolone Pivalate |
92 | Fluphenazine Hydrochloride | — |
93 | Flurandrenolone ....... | — |
94 | Folic Acid........... | Ferrous Sulphate (Dried), B.P., with Folic Acid, B.P. |
95 | Framycetin Sulphate.... | Light Kaolin with Framycetin Sulphate |
|
| Dexamethasone with Framycetin Sulphate and Gramicidin |
|
| Gramicidin and Dexamethasone Metasulphobenzoate with Framycetin Sulphate |
96 | Galactomin, Formula No.17 | — |
97 | Galactomin, Formula No.19 | — |
98 | Glucose and Ketone Indicator | — |
99 | Glucose Indicator, Blood | — |
100 | Glucose Indicator, Urine | — |
101 | Goat’s Milk, Dehydrated | — |
102 | Goat’s Milk.......... | — |
103 | Gramicidin.......... | Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin |
|
| Neomycin Sulphate with Thonzonium Bromide, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Gramicidin |
|
| Framycetin Sulphate with Dexamethasone and Gramicidin |
|
| Framycetin Sulphate with Dexamethasone Metasulphobenzoate and Gramicidin |
|
| Neomycin Sulphate with Nystatin, Triamcinolone Acetonide and Gramicidin |
104 | Guaiphenesin, B.P.C.... | Theophylline with Guaiphenesin, B.P.C. |
105 | Hydrocortisone........ | Polymyxin B Sulphate with Neomycin Sulphate and Hydrocortisone |
|
| Neomycin Sulphate with Hydrocortisone |
|
| Natamycin with Neomycin Sulphate and Hydrocortisone |
106 | Hydrocortisone Acetate.. | Neomycin Sulphate with Hydrocortisone Acetate |
|
| Neomycin Sulphate with Gramicidin, Thonzonium Bromide, Thonzylamine Hydrochloride and Hydrocortisone Acetate |
|
| Oxytetracycline Hydrochloride and Hydrocortisone Acetate |
107 | Hyoscine Hydrobromide.. | Hypromellose 4500 with Hyoscine Hydrobromide |
|
| Papaveretum with Hyoscine Hydrobromide |
|
| Pethidine Hydrochloride with Hyoscine Hydrobromide |
108 | Idoxuridine........... | — |
109 | Ipecacuanha.......... | Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine, B.P.C. 1959, and Ipecacuanha |
110 | “ ISOMIL ”.......... | — |
111 | Isoniazid............ | Sodium Aminosalicylate with Isoniazid |
112 | Isoprenaline Hydrochloride | — |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
113 | Kanamycin Sulphate, B.P.C. | — |
114 | “ KETOVITE ” Liquid .. | — |
115 | Lauryl Dimethylbenzyl Ammonium Chloride | “ TERIC N8 ” with Lauryl Dimethylbenzyl Ammonium Chloride |
116 | Levallorphan Tartrate ... | Pethidine Hydrochloride with Levallorphan Tartrate |
117 | Lignocaine Hydrochloride | Polymyxin P. Sulphate with Propylene Glycol and Lignocaine Hydrochloride |
118 | Lincomycin Hydrochloride | — |
119 | Locasol ............. | — |
120 | Lofenalac............ | — |
121 | Lynoestrenol......... | Mestranol with Lynoestrenol |
122 | Lypressin............ | — |
123 | Magnesium Aluminium Hydroxide | — |
124 | Magnesium Chloride.... | Sodium Chloride with Ammonium Chloride, Potassium Chloride and Magnesium Chloride |
|
| Sodium Chloride with Potassium Chloride, Sodium Lactate and Magnesium Chloride |
|
| Sodium Chloride with Sodium Acetate, Sodium Gluconate, Potassium Chloride and Magnesium Chloride |
125 | Magnesium Hydroxide, B.P.C. | Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. |
|
| Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine |
|
| Aluminium Hydroxide Gel Dried with Magnesium Hydroxide, B.P.C. |
|
| Aluminium Hydroxide Gel Dried with Magnesium Trisilicate and Magnesium Hydroxide, B.P.C. |
126 | Mebhydrolin Napadisylate, B.P.C. | — |
127 | Meclozine Hydrochloride | Ergotamine Tartrate with Caffeine and Meclozine Hydrochloride |
128 | Medrysone........... | — |
129 | Megestrol Acetate ...... | Ethinyloestradiol with Megestrol Acetate |
130 | Meglumine........... | Theophylline with Meglumine |
131 | Mestranol............ | Ethynodiol Diacetate with Mestranol |
|
| Lynoestrenol with Mestranol |
|
| Norethisterone with Mestranol |
|
| Norethynodrel with Mestranol |
132 | Methacycline Hydrochloride | — |
133 | Methdilazine Hydrochloride | — |
134 | Methenamine Mandelate.. | — |
135 | Methylprednisolone .... | — |
136 | Morphine Tartrate ...... | Morphine Tartrate with Tacrine |
137 | Nalidixic Acid, B.P.C. | — |
138 | Naphazoline Nitrate..... | Naphazoline Nitrate with Antazoline Sulphate |
139 | Natamycin........... | Neomycin Sulphate with Hydrocortisone and Natamycin |
140 | Neomycin Sulphate..... | Hydrocortisone Acetate with Neomycin Sulphate |
|
| Hydrocortisone with Neomycin Sulphate |
|
| Colistin Sulphate with Neomycin Sulphate |
|
| Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate |
|
| Kaolin with Neomycin Sulphate |
|
| Polymyxin B Sulphate with Gramicidin and Neomycin Sulphate |
|
| Polymyxin B Sulphate with Hydrocortisone and Neomycin Sulphate |
|
| Bacitracin with Polymyxin B Sulphate and Neomycin Sulphate |
|
| Thonzonium Bromide with Thonzylamine Hydrochloride, Hydrocortisone Acetate, Gramicidin and Neomycin Sulphate |
|
| Gramicidin with Nystatin, Triamcinolone Acetonide and Neomycin Sulphate |
|
| Natamycin with Hydrocortisone and Neomycin Sulphate |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
141 | Neomycin Undecenoate...... | Bacitracin Zinc with Neomycin Undecenoate |
142 | Neostigmine Methylsulphate... | — |
143 | Nicotinamide............. | Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D |
144 | Nitrofurantoin............. | — |
145 | Noradrenaline Acid Tartrate.... | — |
146 | Norethisterone............ | Mestranol with Norethisterone |
147 | Norethisterone Acetate....... | Ethinyloestradiol with Norethisterone Acetate |
148 | Norethynodrel............. | Mestranol with Norethynodrel |
149 | Norgestrel............... | Ethinyloestradiol with Norgestrel |
150 | Nortriptyline Hydrochloride.... | — |
151 | Nystatin................. | Tetracycline, B.P.C. with a buffering agent and Nystatin |
|
| Demethylchlortetracycline with Nystatin |
|
| Tetracycline Hydrochloride with Nystatin |
|
| Gramicidin with Neomycin Sulphate, Triamcinolone Acctonide and Nystatin |
|
| Oxytetracycline Dihydrate with Nystatin |
152 | Nutramigen.............. | — |
153 | Octatropine Methylbromide.... | — |
154 | Orciprenaline Sulphate....... | — |
155 | Oxytetracycline Dihydrate..... | Nystatin with Oxytetracycline Dihydrate |
156 | Oxytetracycline Hydrochloride.. | Polymyxin B Sulphate with Oxytetracycline Hydrochloride |
|
| Hydrocortisone Acetate with Oxytetracycline Hydrochloride |
157 | Oxethazaine.............. | Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine |
158 | Oxytocin................ | Ergometrine Maleate with Oxytocin |
159 | Pancreatin............... | — |
160 | Pancreatin Enzyme, 4 times U.S.N.F.XII strength | — |
161 | Papaveretum, B.P.C......... | Hyoscine Hydrobromide with Papaveretum, B.P.C. |
162 | Penicillin, Benthamine, B.P.C... | Procaine Penicillin with Benethamine Penicillin, B.P.C. and Sodium Penicillin |
163 | Penicillin, Benzathine........ | Procaine Penicillin with Potassium Penicillin and Benzathine Penicillin |
164 | Penicillin, Benzyl.......... | Procaine Penicillin with Benzyl Penicillin |
165 | Penicillin, Phenoxymethyl (Benzathine, Hydrabamine, or Calcium Salt) | — |
166 | Penicillin, Potassium........ | Benzathine Penicillin with Procaine Penicillin and Potassium Penicillin |
167 | Penicillin, Procaine......... | Benethamine Penicillin, B.P.C. with Sodium Penicillin and Procaine Penicillin |
|
| Benzathine Penicillin with Potassium Penicillin and Procaine Penicillin |
|
| Benzyl Penicillin with Procaine Penicillin |
168 | Penicillin, Sodium.......... | Procaine Penicillin with Benethamine Penicillin, B.P.C. and Sodium Penicillin |
169 | Pentobarbitone............ | Barbitone Sodium with Phenobarbitone Sodium and Pentobarbitone |
170 | Pericyazine............... | — |
171 | Pertussis Vaccine........... | Diphtheria, Tetanus (Purified Toxoid Aluminium Phosphate Adsorbed) and Pertussis Vaccine |
172 | Pethidine Hydrochloride...... | Levallorphan Tartrate with Pethidine Hydrochloride |
|
| Hyoscine Hydrobromide with Pethidine Hydrochloride |
173 | Phenethicillin Benzathine..... | — |
174 | Phenethicillin Potassium...... | Purified Water, B.P., with Phenethicillin Potassium |
175 | Pheniramine Maleate........ | — |
176 | Phenytoin, B.P.C. .......... | — |
177 | Pholcodine............... | — |
178 | Pipenzolate Methobromide.... | — |
179 | Pituitary (Posterior Lobe), Powdered, B.P.C. | — |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
180 | “PK AID I” ............. | — |
181 | “PK AID II” ............. | — |
182 | Plasma Substitute (Polypeptide) | — |
183 | Polyisobutylene .......... | — |
184 | Polymyxin B Sulphate....... | Chloramphenicol with Polymyxin B Sulphate |
|
| Oxytetracycline Hydrochloride with Polymyxin B Sulphate |
|
| Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate |
|
| Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin |
|
| Propylene Glycol with Acetic Acid and Polymyxin B Sulphate |
|
| Neomycin Sulphate with Hydrocortisone and Polymyxin B Sulphate |
|
| Bacitracin with Neomycin Sulphate and Polymyxin B Sulphate |
|
| Lignocaine Hydrochloride with Propylene Glycol and Polymyxin B Sulphate |
185 | Polyvinyl Alcohol ......... | Pilocarpine Nitrate and Polyvinyl Alcohol |
186 | Prednisolone ............ | — |
187 | Prednisolone Acetate....... | Prednisolone Acetate with Phenylephrine Hydrochloride, B.P. |
188 | Prednisolone Sodium Phosphate | — |
189 | Primidone .............. | — |
190 | Promethazine Hydrochloride.. | — |
191 | Pseudoephedrine Hydrochloride | — |
192 | Pyrantel Embonate......... | — |
193 | Pyridoxine Hydrochloride.... | Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride |
194 | Prosobee ............... | — |
195 | Riboflavine.............. | Vitamin A with Thiamine Hydrochloride, Nicotinamide, Ascorbic Acid, Vitamin D and Riboflavine |
196 | Salbutamol .............. | — |
197 | Silver Nitrate, Toughened.... | — |
198 | Sobee ................. | — |
199 | Sodium Acetate........... | Sodium Chloride with Potassium Chloride, Magnesium Chloride, Sodium Gluconate and Sodium Acetate |
200 | Sodium Acid Citrate........ | — |
201 | Sodium Gluconate......... | Sodium Chloride with Sodium Acetate, Potassium Chloride, Magnesium Chloride and Sodium Gluconate |
202 | Sodium Lactate ........... | Potassium Chloride with Sodium Chloride and Sodium Lactate |
|
| Potassium Chloride with Magnesium Chloride, Sodium Chloride and Sodium Lactate |
|
| Potassium Chloride with Dextrose and Sodium Lactate |
|
| Sodium Chloride with Dextrose and Sodium Lactate |
|
| Sodium Chloride with Sodium Lactate |
203 | Sodium Tauroglycocholate, B.P.C. 1954 | Cascara Dry Extract with Phenolphthalein, Capsicum Oleoresin and Sodium Tauroglycocholate, B.P.C. 1954 |
204 | Sorbitol ................ | Amino Acids with Sorbitol |
|
| Amino Acids with Sorbitol and Alcohol |
205 | Soyalac ................ | — |
206 | Sterculia | — |
207 | Strychnine, B.P.C. 1959 | Phenolphthalein with Aloin, Dry Extract of Belladonna, Ipecacuanha and Strychnine, B.P.C. 1959 |
208 | Sulphafurazole ........... | — |
209 | Sulphamethizole .......... | — |
210 | Sulphamethoxazole......... | Trimethoprim with Sulphamethoxazole |
211 | Sulphaphenazole, B.P.C...... | — |
212 | Surgical Cement | — |
213 | Surgical Cement Solvent..... | — |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
214 | Tacrine .................. | Morphine Sulphate with Tacrine |
|
| Morphine Tartrate with Tacrine |
215 | Terbutaline Sulphate......... | — |
216 | “ TERIC N8 ” ............. | Lauryl Dimethylbenzyl Ammonium Chloride with “ TERIC N8 ” |
217 | Testosterone Decanoate....... | Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
218 | Testosterone Isocaproate....... | Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate |
|
| Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
219 | Testosterone Phenylpropionate... | Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate |
|
| Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
220 | Testosterone Propionate....... | Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate |
|
| Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
221 | Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed) | Diphtheria and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed) |
|
| Diphtheria, Pertussis and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed) |
222 | Tetracycline, B.P.C. ......... | Tetracycline, B.P.C. with a buffering agent |
|
| Tetracycline, B.P.C. with a buffering agent and Amphotericin B |
|
| Tetracycline, B.P.C. with a buffering agent and Nystatin |
223 | Tetracycline Hydrochloride..... | Tetracycline Hydrochloride with Nystatin |
|
| Procaine Hydrochloride with Tetracycline Hydrochloride |
224 | Thiamine Hydrochloride....... | Riboflavine with Nicotinamide, Ascorbic Acid, Vitamin A, Vitamin D and Thiamine Hydrochloride |
225 | Thioridazine .............. | — |
226 | Thiotepa ................. | — |
227 | Thonzonium Bromide........ | Neomycin Sulphate with Gramicidin, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Thonzonium Bromide |
228 | Thonzylamine Hydrochloride... | Neomycin Sulphate with Gramicidin, Hydrocortisone Acetate, Thonzonium Bromide and Thonzylamine Hydrochloride |
229 | Tiemonium Iodide........... | — |
230 | Triamcinolone Acetonide...... | Gramicidin with Neomycin Sulphate, Nystatin and Triamcinolone Acetonide |
231 | Triclofos Sodium........... | — |
232 | Trifluoperazine Hydrochloride... | — |
233 | Triglycerides Oil, Medium Chain. | — |
234 | Triglyde ................. | — |
235 | Trimeprazine Tartrate, B.P.C.... | — |
236 | Trimethoprim ............. | Trimethoprim with Sulphamethoxazole |
237 | Triprolidine Hydrochloride | — |
238 | Vinyl Acetate ............. | Vinyl Pyrrolidone with Vinyl Acetate and Benzocaine |
239 | Vinyl Pyrrolidone ........... | Vinyl Acetate with Vinyl Pyrrolidone and Benzocaine |
240 | Viprynium Embonate......... | — |
241 | Vitamin A ................ | Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin D and Vitamin A |
242 | Vitamin D ................ | Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin A and Vitamin D |
243 | “ ZERODOR ” ............. | — |
244 | “ ZOFF ” ................ | — |
THIRD SCHEDULE Regulation 11
Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia
1. Acepifylline
2. Acetazolamide Sodium
3. Acetohexamide
4. Acetylcholine Chloride
5. Acetylcysteine
6. Acetyl Sulphafurazole
7. Acidified Golden Syrup, A.P.F. 1955
8. Acriflavine, B.P.C. 1963
9. Acrylic Resin
10. Adrenaline Hydrochloride
11. Albumaid XP
12. Alginic Acid Compound
13. Aloin, B.P.C.
14. Almond Oil Volatile Bitter, B.P.C. 1959
15. Aloxiprin
16. Aluminium Acetate Solution, B.P.C.
17. Aluminium Hydroxide Mixture, A.P.F.
18. Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex
19. Aluminium Sodium Silicate
20. Amantadine Hydrochloride
21. Amaranth Solution, A.P.F.
22. Amaranth Solution, Compound, A.P.F.
23. Amaranth Solution, B.P.C.
24. Ambenonium Chloride
25. Amiloride Hydrochloride
26. Amino Acids
27. Aminogran
28. Aminosalicylic Acid
29. Amitriptyline Embonate
30. Ammonia Aromatic Spirit, B.P.C.
31. Ammonia Solution, Strong, B.P.C.
32. Ammonium Acetate Solution, Strong, B.P.C.
33. Ammonium Bicarbonate, B.P.C.
34. Amphotericin B
35. Angiotensin Amide
36. Antazoline Sulphate
37. Anti-Haemophilic Factor of Animal Origin
38. Attapulgite
39. Bacitracin Zinc
40. “ BANISH ”
41. Belladonna Suppository, B.P. 1948
42. Benzalkonium Chloride
43. Benzoin Compound Tincture, B.P.C.
44. Betahistine Hydrochloride
45. Betamethasone Acetate
46. Betamethasone Phosphate
47. Bethanechol Chloride
48. Black Snake Antivenene
49. Biperiden Hydrochloride
50. Bismuth Subgallate, B.P.C.
51. Brompheniramine Maleate
52. Brown Snake Antivenene
53. Buchu Concentrated Infusion, B.P.C. 1954
54. Cade Oil, B.P.C.
55. Caffeine and Sodium Benzoate, B.P.C. 1954
56. Caffeine Citrate, B.P.C. 1959
57. Calcium Di-Oxytetracycline
58. Calcium Gluconogalactogluconate
59. Calcium Lactate-Gluconate
60. Capreomycin Sulphate
61. Capsicum Ointment, B.P.C.
62. Capsicum Oleoresin
63. Carbenoxolone Sodium
64. Carbinoxamine Maleate
65. Cardamom Aromatic Tincture, B.P.C.
66. Catechu Tincture, B.P.C.
67. Cephalexin Monohydrate
68. Ceratonia, B.P.C. 1949
69. Cetomacrogol Emulsifying Wax, B.P.C.
70. Charcoal
71. Chloramine, B.P.C.
72. Chloramphenicol Palmitate, B.P.C.
73. Chloramphenicol Stearate
74. Chloramphenicol Succinate
75. Chlorhexidine Acetate
76. Chlorhexidine Gluconate
77. Cholestyramine
78. Clemastine Hydrogen Fumarate
79. Clemizole Hydrochloride
80. Clemizole Tannate
81. Clindamycin Hydrochloride
82. Clonidine Hydrochloride
83. Clopamide
84. Clorexolone
85. Coal Tar, B.P.C.
86. Coal Tar Solution Strong, B.P.C.
87. Cochineal Tincture, B.P. 1948
88. Coconut Oil, B.P.C. 1949
89. Colaspase
90. Colophony Ointment, B.P.C. 1959
91. Copper Sulphate, B.P.C.
92. Creosote, B.P.C. 1959
93. Cyclothiazide
94. Cycrimine Hydrochloride
95. Cymogran
96. Cytarabine Hydrochloride
97. Danthron
98. Daunorubicin
99. Death Adder Antivenene
100. Debrisoquine
101. Demecarium Bromide
102. Deslanoside
103. Dexamethasone Metasulphobenzoate
104. Dexamethasone Sodium Phosphate
105. Dexchlorpheniramine Maleate
106. Dextrans
107. Dextriferron
108. Dextrose Polymer
109. Diazoxide
110. Dibenzepin Hydrochloride
111. Diethanolamine Fusidate, B.P.C.
112. Dihydroergotamine Mesylate
113. Dihydroergotoxine Mesylate
114. Dihydrostreptomycin Sulphate, B.P. 1958
115. Dimethicone, B.P.C.
116. Dimethindene Maleate
117. Dioctyl Sodium Sulphosuccinate, B.P.C.
118. Diphenylpyraline Hydrochloride
119. Diphtheria Vaccine (Purified toxoid aluminium phosphate) diluted
120. Diphtheria and Tetanus Vaccine, Adult
121. Dipyridamole
122. Doxepin Hydrochloride
123. Doxylamine Succinate
124. Droperidol
125. Ephedrine, B.P.C.
126. Epicillin
127. Erythrityl Tetranitrate
Third Schedule—continued
128. Erythromycin Ethyl Succinate
129. Erythromycin Glucoheptonate
130. Erythromycin Lactobionate
131. Ethanolamine Oleate
132. Ethoxzolamide
133. Ethylidene Dicoumarin
134. Ethylnoradrenaline Hydrochloride
135. Ethyloestrenol
136. Ferric Hydroxide
137. Ferrous Aminoacetosulphate
138. Ferrous Phosphate Compound, Syrup, B.P.C.
139. Fluclorolone Acetonide
140. Flumethasone Pivalate
141. Fluorothacil Sodium
142. Fluphenazine Decanoate
143. Fluphenazine Enanthate
144. Flurandrenolone
145. Framycetin Sulphate
146. Galactomin, Formula No. 17
147. Galactomin, Formula No. 19
148. Gall and Opium Ointment, B.P.C. 1963
149. Gelsemium Tincture, B.P.C.
150. Ginger Syrup, B.P.C.
151. Glibenclamide
152. Glucagon Hydrochloride
153. Glucose and Ketone Indicator
154. Glucose Indicator—Blood
155. Glucose Indicator—Urine
156. Glycerophosphate Compound Syrup, A.P.F.
157. Glycopyrronium Bromide
158. Glymidine
159. Goat’s Milk, Dehydrated
160. Goat’s Milk, Whole (Sterilised)
161. Gramicidin
162. Guaiphenesin, B.P.C.
163. Hamamelis Liquid Extract, B.P.C.
164. Heparin Calcium
165. Hexocyclium Methylsulphate
166. Haemodialysis Fluid—Concentrate
167. Hexamine Hippurate
168. Hydrargaphen
169. Hydromorphone Hydrochloride
170. Hydroxyurea
171. Hyoscine Butylbromide
172. Hyoscine Methobromide
173. Hypophosphorous Acid, Dilute, B.P.C. 1963
174. Hypromellose 4500
175. Ibuprofen
176. Influenza Vaccine—Sub Unit Type (Desoxycholate Treated)
177. Injection of Amino Acids with Sorbitol and Alcohol
178. Injection of Casein Hydrolysate with Laevulose and Alcohol
179. Injection of Dextran with Dextrose
180. Injection of Potassium Chloride with Sodium Lactate and Dextrose
181. Injection of Sodium Chloride with Potassium Chloride, Calcium Chloride and Dextrose
182. Injection of Sodium Chloride with Sodium Lactate and Dextrose
183. Insect Allergen Extract—Honey Bee
184. Insect Allergen Extract—Jumper Ant
185. Insect Allergen Extract—Paper Wasp
186. Insulin Injection, specially purified
187. Insulin Isophane Injection, specially purified
188. Insulin Injection, Special P (Pig)
189. Intraperitoneal Dialysis Solutions
190. Invert Sugar
191. Iron Polymaltose Complex
192. “ ISOMIL ”
193. Isoprenaline Hydrochloride
194. Isopropamide Iodide
195. Kanamycin Sulphate, B.P.C.
196. “ KETOVITE ” Liquid
197. “ KETOVITE ” Tablets
198. Lactulose
199. Lanatoside-C
200. Lauryl Dimethyl Benzyl Ammonium Chloride
201. Lavender Spike Oil, B.P.C.
202. Lead Subacetate Dilute Solution
203. Lead Subacetate Strong Solution, B.P.C.
204. Lemon Oil Terpeneless, B.P.C.
205. Lemon Tincture, B.P. 1958
206. Leucovorin
207. Lipopancreatin
208. Lobelia Ethereal Tincture, B.P.C.
209. Locasol
210. Lofenalac
211. Lypressin
212. Magenta, B.P.C.
213. Magnesium-Aluminium Hydroxide
214. Magnesium Hydroxide, B.P.C.
215. Maphenide Acetate
216. Mebeverine Hydrochloride
217. Mebhydrolin Napadisylate, B.P.C.
218. Medroxyprogesterone Acetate
219. Medrysone
220. Mepenzolate Bromide
221. Mercaptomerin Sodium
222. Mercuric Chloride, B.P.C.
223. Metaraminol Bitartrate
224. Methaqualone Hydrochloride
225. Methdilazine Hydrochloride
226. Methenamine Mandelate
227. Methenolone Acetate
228. Methoxamine Hydrochloride, B.P.C.
229. Methsuximide
230. Methyclothiazide
231. Methylphenobarbitone, B.P.C. 1963
232. Methylprednisolone Acetate
233. Methylprednisolone Sodium Succinate
234. Methysergide Maleate
235. Minocycline Hydrochloride
236. Morphine Tartrate
237. Myrrh Tincture, B.P.C.
238. Nalidixic Acid, B.P.C.
239. Nandrolone Hexoxyphenyl Propionate
240. Natamycin
241. Neomycin Undecenoate
242. Nitromin
243. Norgestrel
244. Nutramigen
245. Octatropine Methylbromide
246. Oestradiol Valerate
247. Oestrone, B.P.C. 1954
248. Oily Ophthalmic Vehicle, A.P.F. 1955
249. Orange Syrup, B.P.C.
250. Orange Tincture, B.P.C.
251. Oxazepam
252. Oxethazaine
253. Oxprenolol Hydrochloride
254. Oxycodone Pectinate
Third Schedule—continued
255. Oxymel, B.P.C.
256. Oxymel of Squill, B.P.C.
257. Oxymetholone
258. Oxyphenonium Bromide
259. Oxytetracycline
260. Oxytocin
201. Pancreatin Enzyme, U.S.N.F. XII
262. Papaveretum, B.P.C.
263. Paraben Ophthalmic Phosphate Buffer, A.P.F.
264. Paraben Ophthalmic Vehicle, A.P.F. 1955
265. Paraffin Liquid Light, B.P.C. 1963
266. Paramethasone Acetate
267. Pectin
268. Penicillinase
269. Penicillin Benethamine, B.P.C.
270. Pentacrythritol Tetranitrate, diluted, B.P.C.
271. Pentazocine Lactate
272. Penthienate Methobromide
273. Pentobarbitone
274. Pericyazine
275. Pheniramine Maleate
276. Pheniramine Para-Aminosalicylate
277. Phenol Ointment, B.P. 1948
278. Phenoxymethylpenicillin, Benzathine
279. Phenoxymethylpenicillin, Hydrabamine
280. Phensuximide, B.P.C.
281. Phenthimentonium
282. Phenytoin, B.P.C.
283. Phthalylsulphacetamide
284. Physostigmine, B.P.C.
285. Pilocarpine Hydrochloride
286. Pipenzolate Methobromide
287. Pituitary Hormone, Follicle-stimulating, Human
288. Pituitary Hormone, Growth, Human
289. Pituitary (Posterior Lobe) Powdered, B.P.C.
290. Pizotifen Malate
291. “ PK AID I ”
292. “ PK AID II ”
293. Plasma Substitute (Polypeptide)
294. Polyisobutylene
295. Polyoestradiol Phosphate
296. Polyvinyl Alcohol
297. Potassium Chlorate, B.P.C.
298. Potassium Effervescent Tablets 299. Practolol
300. Prednisolone Acetate
301. Prednisolone Sodium Succinate
302. Prednisolone Steaglate
303. Prednisolone Tertiary Butyl Acetate
304. Prindolol
305. Procarbazine Hydrochloride
306. Prochlorperazine
307. Proscillaridin
308. Prosobee
309. Pseudoephedrine Hydrochloride
310. Pumilio Pine Oil, B.P.C.
311. Pyrantel Embonate
312. Pyridine Aldoxime Methiodide
313. Quillaia Tincture, B.P.C.
314. Quinethazone
315. Quinidine Bisulphate
316. Raspberry Syrup, B.P.C.
317. Rauwolfia Alkaloids
318. Rauwolfia Serpentina, B.P.C.
319. Red Back Spider Antivenene
320. Rolitetracycline
321. Rosemary Oil, B.P.C.
322. Salbutamol Sulphate
323. Salicylamide
324. Secbutobarbitone Sodium
325. Senega, Concentrated Infusion, B.P.C. 1968
326. Siberian Fir Oil, B.P.C. 1949
327. Silver Protein, B.P.C.
328. Silver Protein Mild, B.P.C.
329. Snake Bite Antivenene—Polyvalent
330. Sobee
331. Sodium Gluconate
332. Sodium Hypochlorite Solution, Strong, B.P.C.
333. Sodium Lactate
334. Sodium Lactate Compound Injection, B.P. with Dextrose
335. Sodium Nitroprusside
336. Sodium Tauroglycocholate, B.P.C. 1554
337. Sorbide Nitrate
338. Soyalac
339. Spectinomycin Dihydrochloride Pentahydrate
340. Squill Tincture, B.P.C.
341. Stanolone
342. Stanozolol
343. Stearic Acid, B.P.C.
344. Sterculia
345. Stilboestrol Diphosphate
346. Stone Fish Antivenene
347. Streptokinase
348. Strychnine, B.P.C. 1959
349. Sulphaphenazole, B.P.C.
350. Sulphasalazine
351. Sulphasymazine
352. Sulphurated Potash, B.P.C.
353. Sulphur Sublimed, B.P.C.
354. Surgical Cement
355. Surgical Cement Solvent
356. Tacrine
357. Taipan Antivenene
358. Tartrazine, B.P.C. 1954
359. Terbutaline Sulphate
360. “ TERIC N8 ”
361. Testosterone Decanoate
362. Testosterone Enanthate
363. Testosterone Isocaproate
364. Tetracosactrin
365. Tetracycline, B.P.C.
366. Thiabendazole
367. Thiethylperazine Malate
368. Thiethylperazine Maleate
369. Thiopropazate Hydrochloride
370. Thioridazine
371. Thonzonium Bromide
372. Thonzylamine Hydrochloride
373. Thyrotropin
374. Tiemonium Iodide
375. Tiger Snake Antivenene
376. Titanium Dioxide, B.P.C.
377. Tolazamide
378. Tragacanth Mucilage
379. Tridihexethyl Chloride
380. Triethanolamine, B.P.C.
381. Triglycerides Oil, Medium Chain
382. Triglyde
383. Trimeprazine Tartrate, B.P.C.
384. Trolnitrate Phosphate
385. Typhoid Vaccine
Third Schedule—continued
386. Vancomycin Hydrochloride
387. Vanillin
388. Vasopressin Tannate.
389. Verapamil
390. Vincristine Sulphate
391. Vinyl Acetate
392. Vinyl Pyrrolidone
393. Vitamin A
394. Vitamin D
395. “ ZERODOR ”
396. Zinc Gelatin, B.P.C.
397. “ ZOFF ”
_______________
FOURTH SCHEDULE Regulation 12
Additives
1. Acetone, B.P.C.
2. Alcohol (95%), B.P.
3. Arachis Oil, B.P.
4. Amethocaine Hydrochloride, B.P.
5. Camphor, B.P.
6. Carmine Solution, A.P.F.
7. Castor Oil, B.P.
8. Citronella Oil, B.P.C.
9. Chlorhexidine Gluconate Solution, B.P.
10. Chloroform, B.P.
11. Concentrated Anise Water, B.P.C.
12. Concentrated Cinnamon Water, B.P.C.
13. Concentrated Peppermint Water, B.P.
14. Dextrose Monohydrate, B.P.
15. Dilute Alcohols, B.P.
16. Ether Anaesthetic, B.P.
17. Eucalyptol, B.P.C.
18. Eucalyptus Oil, B.P.
19. Honey—Purified, B.P.C.
20. Hypromellose 4500
21. Maize Oil, B.P.
22. Methylcellulose 450
23. Olive Oil, B.P.
24. Peppermint Oil, B.P.
25. Sodium Thiosulphate, B.P.C.
26. Solution of Burnt Sugar, B.P.C. 1959
27. Solvent Ether
28. Spirit, Methylated, Industrial, B.P.
29. Syrup of Pholcodine Citrate, B.P.C. 1959
30. Turpentine Oil, B.P.
31. Xylene, B.P.C. 1949
FIFTH SCHEDULE Regulation 14
Pharmaceutical Benefits the Prescribing of which is Subject to Conditions and Restrictions
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
1 | Acetylcysteine............... | Cystic fibrosis (mucoviscidosis) |
2 | Aspirin with Paracetamol and Caffeine Tablets | Any disease or condition in a pensioner |
3 | Acrylic Resin................ | Ileostomy or colostomy conditions |
4 | Albumaid XP................ | With the written authority of the Director-General, phenylketonuria |
5 | Alginic Acid Compound Granules.. | Reflux oesophagitis |
6 | Alginic Acid Compound Powder... | Oesophageal reflux in infants |
7 | Alprenolol Injection, B.P. ........ | Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Dissecting aneurysm (aortic) |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
8 | Alprenolol Tablets, B.P.......... | Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Dissecting aneurysm (aortic) |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
|
| Treatment of severe hypertensive disease where other treatment has proved ineffective |
9
| Amantadine Hydrochloride.......
| With the written authority of the Director-General, the treatment of Parkinson’s disease caused otherwise than by treatment with a drug |
10 | (1) Aminocaproic Acid, B.P....... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Aminocaproic Acid Injection, B.P. | |
11 | Aminogran.................. | With the written authority of the Director-General, phenylketonuria |
12 | Aminosalicylic Acid............ | Tuberculosis |
13 | Amphotericin B Injection........ | Systemic mycoses |
14 | (1) Ampicillin Capsules, B.P....... | Infections by organisms sensitive to Ampicillin where the infection cannot be safely and effectively treated with sulphonamides or with any of the following administered orally— |
| (2) Ampicillin Injections and Tablets. | |
| (3) Ampicillin Trihydrate, B.P., with Purified Water, B.P. | Benzylpenicillin |
| Phenoxymethylpenicillin | |
|
| Phenethicillin |
|
| Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Ampicillin |
|
| Urinary tract infections where the patient is sensitive to sulphonamides |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
15 | Ascorbic Acid Tablets, B.P........ | Any disease or condition in a pensioner |
16 | Azathioprine ................ | With the written authority of the Director-General— |
|
| Anaemia, autoimmune haemolytic |
|
| Arthritis, rheumatoid with vasculitis or visceral complications |
|
| Crohn’s disease |
|
| Dermatomyositis |
|
| Granulomatosis, Wegener’s |
|
| Hepatitis, active, chronic |
|
| Lupus erythematosus, systemic |
|
| Nephritis |
|
| Nephrotic syndrome |
|
| Organ transplant |
|
| Polyarteritis nodosa |
|
| Scleroderma |
|
| Thrombocytopenic purpura |
|
| Ulcerative colitis |
17 | “ BANISH ” ................ | Ileostomy or colostomy conditions |
18 | Benzathine Penicillin, B.P........ | Prophylaxis of recurrent streptococcal infections (including rheumatic fever) |
19 | Benzoin Compound Tincture, B.P.C., aerosol spray | Ileostomy or colostomy conditions |
20 | Benzylpenicillin Injection, 5,000,000 units | Bacterial endocarditis or septicaemia |
21 | Benzylpenicillin Injection, 10,000,000 units | Bacterial endocarditis or septicaemia |
| Gastrointestinal surgery | |
22 | (1) Benzylpenicillin with Streptomycin Sulphate | Endocarditis due to streptococcus faecalis or streptococcus viridans |
| (2) Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate |
|
23 | Betahistine Hydrochloride | Meniere’s syndrome |
24 | Betamethasone Acetate with Betamethasone Injection | Alopecia areata |
| Granulomata, dermal | |
|
| Intra-articular use |
|
| Keloid |
|
| Lichen planus hypertrophic |
|
| Lichen simplex chronicus |
|
| Lupus erythematosus, chronic discoid |
|
| Uveitis |
|
| With the written authority of the Director-General, pre-operative and post-operative prophylactic therapy for those patients undergoing or recently subjected to steroid therapy |
25 | Bethanechol Chloride........... | Urinary retention due to a neurogenic atonic bladder |
26 | Busulphan Tablets, B.P.......... | Treatment in malignant neoplasia |
27 | (1) Calciferol Tablets, Strong, B.P. | With the written authority of the Director-General— Hypoparathyroidism |
| (2) Calciferol, B.P. | Osteomalacia following gastrectomy or severe steatorrhoea Vitamin D-resistant rickets |
28 | Calcium Aminosalicylate | Tuberculosis |
29 | Calcium Carbonate, B.P., with Calcium Lactate-Gluconate | Hypocalcaemia |
| Hypoparathyroidism | |
|
| Osteoporosis |
30 | Calcium Carbonate, B.P., with Citric Acid, B.P. Compound Effervescent Tablets | Hypocalcaemia |
| Hypoparathyroidism | |
| Osteoporosis | |
31 | Calcium Dioxytetracycline | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic |
|
| Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
32 | Calcium Gluconogalacto-gluconate Tablets | Hypocalcaemia |
| Hypoparathyroidism | |
|
| Osteoporosis |
33 | Capreomycin Sulphate ......... | Tuberculosis |
34 | Carbamazepine Tablets B.P. | Epilepsy |
|
| Trigeminal neuralgia |
35 | Carbenicillin Sodium.......... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| With the written authority of the Director-General, infections where positive bacteriological evidence confirms that carbenicillin is the most appropriate therapeutic agent |
36 | Carbenoxolone Sodium......... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| With the written authority of the Director-General, gastric ulcer where a radiological examination or other appropriate tests have confirmed the presence of a gastric ulcer |
37 | (1) Cephalexin Monohydrate | With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephalexin monohydrate is the most appropriate therapeutic agent |
| (2) Cephalexin Monohydrate with Purified Water, B.P. | |
38 | Cephaloridine............... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephaloridine is the most appropriate therapeutic agent |
39 | Cephalothin Sodium........... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephalothin sodium is the most appropriate therapeutic agent |
40 | Ceratonia .................. | Oesophageal reflux in infants |
41 | Charcoal Tablets............. | Ileostomy or colostomy conditions |
42 | Chlorambucil Tablets, B.P....... | With the written authority of the Director-General— |
|
| Anaemia, autoimmune, haemolytic |
|
| Arthritis, rheumatoid with vasculitis or visceral complications |
|
| Crohn’s disease |
|
| Dermatomyositis |
|
| Granulomatosis, Wegener’s |
|
| Hepatitis, active, chronic |
|
| Lupus erythematosus, systemic |
|
| Malignant disease including leukaemia |
|
| Nephritis |
|
| Nephrotic syndrome |
|
| Polyarteritis nodosa |
|
| Scleroderma |
|
| Thrombocytopenic purpura |
|
| Ulcerative colitis |
43 | Chloramine Deodorant Tablets and powder | Ileostomy or colostomy conditions |
44 | (1) Chloramphenicol Capsules, B.P. | Bacterial meningitis |
| Intraocular infections | |
| (2) Chloramphenicol Injections | Rickettsioses |
| Typhoid | |
| (3) Chloramphenicol Oral Suspension | The treatment of other serious infections in a patient where it is established by appropriate bacteriological testing that chloramphenicol is the only suitable antibiotic listed as a pharmaceutical benefit for use in treating the infection in the patient |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
45 | Chlorotrianisene Tablets | Carcinoma of the prostate |
46 | (1) Chlorpromazine Hydrochloride, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Chlorpromazine Injection, B.P. | Major psychoses including— |
| Major organic psychoses | |
| (3) Chlorpromazine Tablets, B.P. | Manic psychoses |
|
| Paranoid states |
|
| Schizophrenia |
|
| Hereditary chorea (Huntington’s) |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| Severe conduct disorders in patients who have not attained the age of sixteen years |
47 | Chlortetracycline Hydrochloride | Any disease or condition in a pensioner |
48 | Cholestyramine .............. | With the written authority of the Director-General— |
|
| Bile salt malabsorption associated with ileal resection or proven ileal disease |
|
| Pruritis associated with partial biliary obstruction not responding to other therapy |
|
| Initial treatment with cholestyramine of proven hyperbetalipoproteinaemia (type 11) not responding to other therapy |
|
| A second or subsequent course of treatment for proven hyperbetalipoproteinaemia (type 11) in patients who respond to treatment with cholestyramine but do not respond to other therapy |
49 | Clindamycin Hydrochloride | Gram-positive coccal infections where the infection cannot be safely and effectively treated with penicillin, or a derivative of penicillin |
|
| Osteomyelitis |
50 | Clofibrate.................. | With the written authority of the Director-General— |
|
| Diabetic retinopathy (exudative) |
|
| Initial treatment with clofibrate of hyperlipidaemia not responding to dietary therapy |
|
| A second or subsequent course of treatment for hyperlipidaemia where significant lowering of serum cholesterol subsequent to initial treatment with clofibrate has been established by laboratory report |
51 | (1) Cloxacillin Sodium, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Cloxacillin Capsules, B.P. | |
| (3) Cloxacillin Sodium, B.P., with Purified Water, B.P. | With the written authority of the Director-General, serious infections where bacteriological evidence confirms the presence of penicillinase-producing staphylococci |
|
| Osteomyelitis |
52 | (1) Codeine Phosphate with Aspirin Soluble Tablets | Any disease or condition in a pensioner |
| (2) Codeine Phosphate with Aspirin Tablets |
|
| (3) Codeine Phosphate with Aspirin and Paracetamol Soluble Tablets |
|
| (4) Codeine Phosphate with Aspirin and Paracetamol Tablets |
|
| (5) Codeine Phosphate with Aspirin, Paracetamol and Caffeine Tablets |
|
53 | Colaspase.................. | Acute leukaemia |
|
| Malignant neoplasia |
54 | Colistin Sulphomethate Sodium, B.P., for injection | Pyocyancus infection, other gram-negative infections where no other drug is effective |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
55 | Cyanocobalamin Injection, B.P. | Pernicious anaemia and other proven Vitamin B-12 deficiencies |
|
| Post gastrectomy treatment |
|
| Sub-acute combined degeneration of the cord |
|
| Neuroblastoma |
56 | (1) Cyclophosphamide Tablets, B.P. | With the written authority of the Director-General— |
| Anaemia, autoimmune, haemolytic | |
| (2) Cyclophosphamide, B.P. | Arthritis, rheumatoid with vasculitis or visceral complications |
|
| Crohn’s disease |
|
| Dermatomyositis |
|
| Granulomatosis, Wegener’s |
|
| Hepatitis, active, chronic |
|
| Lupus erythematosus, systemic |
|
| Malignant disease, including leukaemia |
|
| Nephritis |
|
| Nephrotic syndrome |
|
| Polyarteritis nodosa |
|
| Scleroderma |
|
| Thrombocytopenic purpura |
|
| Ulcerative colitis |
57 | Cycloserine Capsules, B.P....... | Tuberculosis |
58 | Cymogran ................. | With the written authority of the Director-General, phenylketonuria |
59 | (1) Cyproheptadine Hydrochloride, B.P. | Allergic rhinitis |
| Allergic dermatoses | |
| (2) Cyproheptadine Tablets, B.P. | Migraine |
60 | Cytarabine Hydrochloride....... | Acute leukaemia |
| Malignant neoplasia | |
61 | Daunorubicin ............... | Acute leukaemia |
| Malignant neoplasia | |
62 | Deodorant Detergent Solution (Lauryldimethyl Benzyl Ammonium Chloride and “TERIC N8”) | Ileostomy or colostomy conditions |
63 | Deoxycortone Acetate, B.P. | Adrenal cortical hypofunction |
64 | Desferrioxamine Mesylate....... | Acute iron poisoning |
|
| Hepatolenticular degeneration |
65 | (1) Dextromoramide Tablets, B.P. | Treatment in malignant neoplasia |
| (2) Dextromoramide Tartrate, B.P. |
|
66 | Dextrose Polymer............. | With the written authority of the Director-General, phenylketonuria |
67 | Diazoxide.................. | Hypertensive crisis |
68 | Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride | Vomiting in pregnancy |
69 | (1) Dihydroergotoxine Mesylate Tablets | For the treatment of patients who have suffered an attack of paralytic poliomyelitis |
| (2) Dihydroergotoxine Mesylate Injection |
|
70 | Dihydrotachysterol............ | Hypoparathyroidism |
71 | Dimethicone Aerosol Spray | Ileostomy or colostomy conditions |
72 | Dimethicone Creams........... | Use with surgical appliances |
73 | (1) Dioctyl Sodium Sulphosuccinate | Any disease or condition in a pensioner |
| (2) Dioctyl Sodium Sulphosuccinate with Danthron |
|
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
74 | Dipyridamole............... | Supplementing anticoagulants in— |
|
| Biopsy proven glomerulonephritis |
|
| Microangiopathic renal disease |
|
| Renal allograft |
|
| Patients with cardiac prosthesis |
75 | Doxycycline Hydrochloride Suspension | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic |
|
| Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets |
76 | Droperidol ................. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
77 | (1) Epicillin Capsules | Infections by organisms sensitive to Epicillin where the infection cannot be safely and effectively treated with sulphonamides or with any of the following administered orally— |
| (2) Epicillin with Purified Water, B.P. | |
|
| Benzylpenicillin |
|
| Phenoxymethylpenicillin |
|
| Phenethicillin |
|
| Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Epicillin |
|
| Urinary tract infections where the patient is sensitive to sulphonamides |
78 | Ethacrynic Acid.............. | Fluid retention associated with heart failure, cirrhosis of the liver or nephrotic syndrome |
|
| Fluid retention associated with other conditions and not responding to thiazides |
79 | Ethionamide................ | Tuberculosis |
80 | Ethyloestrenol............... | With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
|
| Osteomalacia following gastrectomy |
81 | Ferrous Sulphate (Dried), B.P., with Folic Acid, B.P. | Prophylactic use during pregnancy |
82 | Fludrocortisone Tablets, B.P. | Adrenal cortical hypoplasia including Addison’s disease |
|
| Orthostatic hypotension |
|
| Total adrenalectomy |
83 | Fluorouracil Sodium | Treatment in malignant neoplasia |
84 | Fluoxymesterone Tablets, B.P. | Eunuchism |
|
| Eunuchoidism |
|
| Carcinoma of the breast |
|
| With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Proven aplastic anaemias |
85 | (1) Fluphenazine Hydrochloride, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Fluphenazine Tablets, B.P. | Major psychoses including— |
| (3) Fluphenazine Enanthate | Major organic psychoses |
| (4) Fluphenazine Decanoate | Manic psychoses |
|
| Paranoid states |
|
| Schizophrenia |
|
| Hereditary chorea (Huntington’s) |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
86 | (1) Folic Acid, B.P. | Cystic fibrosis |
| (2) Folic Acid Tablets, B.P. 5 mg. | Proven folic acid deficiency |
| Sprue or the sprue-like syndrome |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
87 | Folic Acid Tablets, B.P. 0.5 mg. | Cystic fibrosis |
| Pregnancy | |
88 | Framycetin Sulphate Injection | Sub-conjunctival injection in the treatment of serious ocular inflammation |
89 | Framycetin Sulphate Tablets | Bowel sterilization preparatory to major surgery |
90 | Frusemide Tablets, B.P......... | Fluid retention associated with heart failure, cirrhosis of the liver or nephrotic syndrome |
|
| Fluid retention associated with other conditions and not responding to thiazides |
91 | Galactomin Formula No. 17 | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Conditions needing an extreme restriction of lactose in the diet of a patient under the age of four years |
92 | Galactomin Formula No. 19 | With the written authority of the Director-General, glucose-galactose malabsorption |
93 | Gentamicin Sulphate........... | With the written authority of the Director-General— |
|
| Infections where positive bacteriological evidence confirms that gentamicin is the most appropriate antibiotic |
|
| Septicaemia including suspected septicaemia |
94 | Glucose Indicator—Blood....... | Diabetes mellitus, where blood sugar levels cannot be determined to be within a satisfactory range by urine testing |
|
| Hypoglycaemia of infancy |
95 | Goat’s Milk, Dehydrated........ | With the written authority of the Director-General, cow’s milk allergy in children under the age of four years |
96 | Goat’s Milk, Whole (Sterilized) | With the written authority of the Director-General, cow’s milk allergy in children under the age of four years |
97 | (1) Griseofulvin, B.P. | With the written authority of the Director-General, for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination or Wood’s Light |
| (2) Griseofulvin Tablets, B.P. | |
98 | Halibut Liver Oil Capsules....... | Any disease or condition in a pensioner |
99 | Haloperidol................. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| Major psychoses including— |
|
| Major organic psychoses |
|
| Manic psychoses |
|
| Paranoid states |
|
| Schizophrenia |
|
| Hereditary chorea (Huntington’s) |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
100 | Heparin Calcium............. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
101 | Hydrocortisone Acetate Injection, B.P. | Alopecia areata |
| Granulomata, dermal | |
|
| Intra-articular use |
|
| Keloid |
|
| Lichen planus hypertrophic |
|
| Lichen simplex chronicus |
|
| Lupus erythematosus, chronic discoid |
102 | Hydrocortisone Sodium Succinate Injection, 100 mg. | Acute medical or surgical crisis |
| Prophylactic therapy before, during and after surgical procedures for patients requiring or recently subjected to steroid therapy | |
103 | Hydrocortisone Sodium Succinate Injection, 250 mg. and 500 mg. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
104 | Hydroxocobalamin Injection, B.P. | Pernicious anaemia and other proven Vitamin B-12 deficiencies |
|
| Post gastrectomy treatment |
|
| Sub-acute combined degeneration of the cord |
|
| Neuroblastoma |
105 | Hydroxyprogesterone Injection, B.P. | Carcinoma of the endometrium |
106 | Hydroxyurea................ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
107 | Ibuprofen.................. | Rheumatoid arthritis where salicylates are contra-indicated or ineffective |
|
| Osteoarthritis where salicylates are contra-indicated or ineffective |
108 | Idoxuridine ................ | Infections caused by Herpes Simplex Virus |
109 | Influenza Vaccine ............ | For prophylaxis of pensioners only |
110 | Insect Allergen Extract—Honey Bee | Severe constitutional reaction to bee stings |
111 | Insect Allergen Extract—Jumper Ant | Severe constitutional reaction to jumper ant stings |
112 | Insect Allergen Extract—Paper Wasp | Severe constitutional reaction to wasp stings |
113 | “ISOMIL”................. | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
|
| Milk allergy in children who have not attained the age of four years |
114 | Isoniazid Tablets, B.P.......... | Tuberculosis |
115 | Isoprenaline Hydrochloride Tablets, 30 mg. | Stokes-Adams Syndrome |
116 | Kanamycin Sulphate Injections | Infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the most appropriate antibiotic |
|
| Septicaemia, including suspected septicaemia |
117 | (1) “ KETOVITE ” Liquid | With the written authority of the Director-General— |
| (2) “ KETOVITE ” Tablets | Galactosaemia |
|
| Persistent monosaccharide intolerance |
|
| Phenylketonuria |
|
| Tyrosinosis (hereditary) |
118 | Lactulose .................. | Hepatic coma or pre-coma (chronic portosystemic encephalopathy) |
119 | Leucovorin................. | Antidote to folic acid antagonists |
120 | (1) Levodopa Capsules, B.P. | With the written authority of the Director-General, treatment of Parkinson’s Disease |
| (2) Levodopa Tablets, B.P. | |
121 | Lignocaine Injection, B.P........ | Cardiac arrhythmias |
122 | (1) Lincomycin Hydrochloride, B.P. | Gram positive coccal infections where these cannot be safely and effectively treated with a penicillin |
| (2) Lincomycin Capsules, B.P. | Osteomyelitis |
| (3) Lincomycin Injection, B.P. |
|
123 | Liothyronine Tablets, B.P....... | Myxoedema |
124 | Lithium Carbonate Tablets, B.P. | With the written authority of the Director-General, manic depression |
125 | Locasol................... | With the written authority of the Director-General, Hypercalcaemia in children under the age of two years |
126 | Lofenalac.................. | With the written authority of the Director-General, phenylketonuria |
127 | Lypressin Nasal Spray.......... | Diabetes insipidus |
128 | Maphenide Acetate............ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
129 | Medroxyprogesterone Acetate Tablets, 2.5 mg. | Precocious puberty |
| Turner’s syndrome | |
130 | Medroxyprogesterone Acetate Tablets, 10 mg. | Precocious puberty |
Turner’s syndrome |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
131 | Medroxyprogesterone Acetate Tablets, 100 mg. | Carcinoma of the breast |
| Carcinoma of the endometrium | |
| Hypernephroma | |
132 | Medroxyprogesterone Acetate Injections, 50 mg. in 1 ml. or 250 mg. in 5 ml. | Carcinoma of the endometrium |
| Hypernephroma | |
133 | Medroxyprogesterone Acetate Injections, 150 mg. in 1 ml. | Carcinoma of the endometrium |
| Hypernephroma | |
|
| Precocious puberty |
134 | Megestrol Acetate, B.P., with Ethinyloestradiol, B.P. | Severe acne in females |
| Hirsutism in females | |
|
| Sexual infantilism in females |
135 | Melphalan Tablets, B.P......... | Treatment in malignant neoplasia |
136 | Mercaptopurine Tablets, B.P. | Allergic granulomatous angiitis |
|
| Lupus erythematosus |
|
| Nephrotic syndrome |
|
| Periarteritis (nodosa) |
|
| Treatment in malignant neoplasia |
137 | Methacycline Hydrochloride, B.P. | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic |
|
| Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets |
138 | (1) Methandienone Tablets, B.P. | With the written authority of the Director-General— |
| Intermittent use for corticosteroid-induced osteoporosis | |
| (2) Methenolone Acetate | Intermittent use for patients on long-term treatment with corticosteroids |
139 | Methicillin Sodium, B.P., for Injection | Proven or suspected staphylococcal septicaemia |
146 | (1) Methotrexate Tablets | With the written authority of the Director-General— |
| (2) Methotrexate Injection | Malignant neoplasia |
|
| Pemphigus vulgaris |
|
| Psoriasis, severe, generalised |
141 | Methylprednisolone Acetate Retention Enema | With the written authority of the Director-General— |
| Colitis, ulcerative, proven by sigmoidoscopy or radiological report | |
|
| Proctitis, proven by sigmoidoscopy |
142 | Methylprednisolone Acetate Injection | Intra-articular use |
143 | Methyltestosterone Tablets, B.P., 5 mg. | Hypogonadism in patients who have not attained the age of sixteen years |
144 | (1) Methyltestosterone Tablets, B.P., 25 mg. or 50 mg. | Carcinoma of the breast |
| Eunuchism | |
| (2) Methyltestosterone, B.P. | Eunuchoidism |
|
| Klinefelter’s syndrome (seminiferous tubule dysgenesis) |
145 | Methysergide Maleate.......... | Carcinoid syndrome |
|
| Treatment of severe recalcitrant migraine where other treatment has failed |
146 | Metyrapone Capsules, B.P....... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
147 | Morphine Sulphate, B.P. with Tacrine Tablets | Severe intractable pain |
148 | Mustine Hydrochloride Injection | Treatment in malignant neoplasia |
149 | Nalidixic Acid............... | Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Nalidixic Acid or where the patient is sensitive to sulphonamides |
|
|
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
150 | Nandrolone Decanoate......... | Carcinoma of the breast |
|
| With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
|
| Severe osteoporosis due to proven pancreatitis |
151 | Nandrolone Hexoxyphenyl Propionate | Carcinoma of the breast |
| With the written authority of the Director-General— | |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
|
| Intermittent use for corticosteroid-induced osteoporosis |
152 | Nandrolone Phenylpropionate Injection, B.P. | Carcinoma of the breast |
| With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis | |
153 | Neomycin Sulphate Powder | With the written authority of the Director-General, use by inhalation in cystic fibrosis (mucoviscidosis) |
154 | Neomycin Tablets, B.P......... | Bowel sterilization preparatory to major surgery |
|
| Encephalopathy, hepatic |
|
| Enteropathogenic E. coli infections in infants |
155 | Nicotinic Acid Tablets, B.P. | Any disease or condition in a pensioner |
156 | (1) Nitrofurantoin Tablets, B.P. | Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Nitrofurantoin or where the patient is sensitive to sulphonamides |
| (2) Nitrofurantoin Oral Suspension | |
157 | Nitromin.................. | Treatment of malignant neoplasia |
158 | Norethisterone Acetate, B.P. | Carcinoma of the breast |
159 | Norethisterone Tablets, B.P. | Endometriosis |
|
| Metropathia haemorrhagica |
|
| Precocious puberty |
|
| Turner’s syndrome |
160 | Nutramigen................. | With the written authority of the Director-General— |
|
| Cow’s milk allergy in children under the age of four years |
|
| Cystic fibrosis (mucoviscidosis) |
|
| Galactosaemia |
|
| Lactose intolerance |
161 | Oxprenolol Hydrochloride Tablets | Dissecting aneurysm (aortic) |
| Idiopathic hypertrophic subaortic stenosis | |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Treatment of severe hypertensive disease where other treatment has proven ineffective |
162 | Oxprenolol Hydrochloride Injection | Idiopathic hypertrophic subaortic stenosis |
| Right ventricular outflow tract obstruction | |
|
| Dissecting aneurysm (aortic) |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
163 | Oxycodone Pectinate.......... | Treatment in malignant neoplasia |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
164 | Oxymetholone............... | With the written authority of the Director-General— |
|
| Proven aplastic anaemias |
|
| Myelosclerosis |
165 | Oxytetracycline Capsules, B.P. 100 mg. | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic |
166 | Oxytetracycline Hydrochloride Ointment | Any disease or condition in a pensioner |
167 | (1) Pancreatin, B.P. | Cystic fibrosis (mucoviscidosis) |
| (2) Pancreatin Enzyme 4X U.S.N.F.XII | Following pancreatico-duodenectomy |
| Pancreatic steatorrhoea | |
| (3) Pancrelipase |
|
168 | (1) Paraffin Liquid Emulsion | Any disease or condition in a pensioner |
| (2) Paraffin Liquid Emulsion with Phenolphthalein |
|
169 | Penicillamine............... | With the written authority of the Director-General— |
|
| Acute heavy metal intoxication |
|
| Cystinosis |
|
| Cystinuria with calculus formation |
|
| Haemoglobinuria, paroxysmal cold |
|
| Wilson’s disease (hepatolenticular degeneration) |
170 | (1) Pericyazine Mesylate | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Pericyazine | |
|
| Major psychoses, including— |
|
| Major organic psychoses |
|
| Manic psychoses |
|
| Paranoid states |
|
| Schizophrenia |
|
| Hereditary chorea (Huntington’s) |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| Severe conduct, disorders in patients who have not attained the ape of sixteen years |
171 | Phytomenadione Injection, 10 mg. per ml. | Antidote to anticoagulants |
| Haemorrhagic diathesis associated with malabsorption | |
172 | Phytomenadione Injection, B.P., 1 mg. in 1 ml. | Antidote to anticoagulants |
| Haemorrhage, diathesis associated with malabsorption | |
|
| Suspected cerebral trauma of the new born |
|
| Haemorrhagic disease of the new born |
173 | Pituitary, Posterior Lobe, Insufflation | Diabetes insipidus |
174 | Pizotifen Malate.............. | The treatment of severe migraine in a patient whose attacks of migraine do not respond to treatment by other therapeutic agents |
175 | (1) “PK AID I” | With the written authority of the Director-General, phenylketonuria |
| (2) “PK AID II” | |
176 | Plasma Substitute (Polypeptide) | Any disease or condition in a patient receiving treatment in or at an approved hospital |
177 | Polyisobutylene.............. | Ileostomy or colostomy conditions |
178 | Polymyxin D. Sulphate Powder | With the written authority of the Director-General, use by inhalation in cystic fibrosis (mucoviscidosis) |
179 | Polyoestradiol Phosphate........ | Carcinoma of the breast |
|
| Carcinoma of the prostate |
180 | Practolol Injection............ | Dissecting aneurysm (aortic) |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
181 | Practolol Tablets............. | Dissecting aneurysm (aortic) |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| |
182 | Prednisolone Sodium Phosphate Retention Enema and Suppository | With the written authority of the Director-General— |
| Ulcerative colitis proven by sigmoidoscopy or radiological report | |
|
| Proctitis proven by sigmoidoscopy |
183 | (1) Prednisolone Acetate Injection | Intra-articular use |
| (2) Prednisolone Butyl Acetate Injection |
|
184 | Prednisolone Acetate with Phenylephrine Hydrochloride, B.P. | Corneal grafts |
Uveitis | ||
185 | Prednisolone Sodium Phosphate Injection, B.P. | Acute medical or surgical crisis |
| Prophylactic therapy before, during and after surgical procedures for patients requiring or recently subjected to steroid therapy | |
186 | Prednisolone Sodium Succinate Injection | Acute medical or surgical crisis |
| Prophylactic therapy before, during and after surgical procedures for patients requiring or recently subjected to steroid therapy | |
187 | Prindolol Injection............ | Dissecting aneurysm (aortic) |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
188 | Prindolol Tablets............. | Dissecting aneurysm (aortic) |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| The treatment of severe hypertensive disease where other treatment has proved ineffective |
189 | Procarbazine Hydrochloride | Treatment in malignant neoplasia |
190 | Promethazine Theoclate Tablets, B.P. | Vomiting in pregnancy |
191 | Propranolol Injection, B.P....... | Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Dissecting aneurysm (aortic) |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act. |
192 | Propranolol Tablets, B.P........ | Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Dissecting aneurysm (aortic) |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
|
| The treatment of severe hypertensive disease where other treatment has proved ineffective |
193 | Proscillaridin................ | Patients intolerant of oral forms of prepared Digitalis, Digoxin and Lanatoside C |
194 | Prosobee.................. | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
|
| Milk allergy in children under the age of four years |
195 | Pyrazinamide............... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
196 | Pyridoxine Hydrochloride Tablets | Anaemia proved to be responsive to Pyridoxine |
| Convulsions responsive to Pyridoxine | |
|
| Homocystinuria |
|
| Primary hyperoxaluria |
|
| Radiation sickness |
|
| Sideroblastic (refractory) anaemia |
|
| Treatment and prophylaxis of peripheral neuritis caused or likely to be caused by isoniazid therapy |
197 | Riboflavine Tablets........... | Any disease or condition in a pensioner |
198 | Senna Tablets, B.P............ | Any disease or condition in a pensioner |
199 | Sobee..................... | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
|
| Milk allergy in children under the age of four years |
200 | (1) Sodium Aminosalicylate Tablets, B.P. | Tuberculosis |
(2) Sodium Aminosalicylate Injection |
| |
(3) Sodium Aminosalicylate Cachets |
| |
(4) Sodium Aminosalicylate with Isoniazid, B.P. |
| |
201 | Sodium Cromoglycate.......... | With the written authority of the Director-General—the treatment of chronic intractable asthma |
202 | (1) Sodium Fusidate | With the written authority of the Director-General, for use in combination with another antibiotic in the treatment of serious staphylococcal infections confirmed by bacteriological evidence |
(2) Diethanolamine Fusidate | ||
203 | Soyalac................... | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
|
| Milk allergy in children under the age of four years |
204 | Spironolactone Tablets, B.P. | With the written authority of the Director-General— |
|
| To supplement other diuretics when these have proved inadequate |
|
| Myasthenia gravis |
|
| Primary hyperaldosteronism |
First Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may he prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
205 | Stanolone .................. | Carcinoma of the breast |
|
| With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
206 | Stanozolol................. | With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
207 | Sterculia................... | Ileostomy or colostomy conditions |
208 | Stilboestrol Diphosphate........ | Carcinoma of the prostate |
209 | Streptokinase ............... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
210 | Sulphasalazine............... | Ulcerative colitis |
211 | (1) Surgical Cement | Ileostomy or colostomy conditions |
| (2) Surgical Cement Solvent | For use with surgical appliances |
212 | (1) Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate | Carcinoma of the breast |
Eunuchism | ||
Eunuchoidism | ||
Klinefelter’s syndrome (seminiferous tubule dysgenesis) | ||
(2) Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
| |
(3) Testosterone Implants, B.P. |
| |
(4) Testosterone Enanthate |
| |
(5) Testosterone Propionate Injection, B.P. |
| |
213 | Tetanus Antitoxin, B.P. (Bovine) | Patients who have previously received an injection of equine serum |
214 | Tetracosactrin............... | With the written authority of the Director-General— |
|
| Hypsarrhythmia |
|
| Treatment of patients who are being withdrawn from long-term corticosteroid therapy |
215 | Tetracycline Capsules, B.P., 100mg. | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic |
216 | Tetracycline Hydrochloride, B.P., Syrup | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic |
|
| Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets |
217 | Tetracycline Hydrochloride with Nystatin, Capsules, 100mg., 125,000 units | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic |
218 | Tetracycline Hydrochloride with Nystatin, Syrups | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic |
|
| Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets |
219 | Tetracycline with a buffering agent, Capsules, 100mg. | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic |
220 | Tetracycline with a buffering agent, Syrups | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic |
|
| Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
221 | Tetracycline with a buffering agent and Amphotericin B | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic |
|
| Treatment of patients who have attained the age of eight years and who are unable to swallow either capsules or tablets |
222 | Tetracycline with a buffering agent and Nystatin, B.P., Capsules, 100mg., 125,000 units | Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic |
223 | Thiamine Hydrochloride Tablets, B.P. | Any disease or condition in a pensioner |
224 | Thiopropazate Hydrochloride | With the written authority of the Director-General— |
|
| Hereditary chorea (Huntington’s) |
|
| Oral dyskinesia |
|
| Phenothiazine-induced choreo-athetosis |
225 | (1) Thioridazine | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Thioridazine Tablets, B.P. | |
|
| Major psychoses including— |
|
| Major organic psychoses |
|
| Manic psychoses |
|
| Paranoid states |
|
| Schizophrenia |
|
| Severe conduct disorders of children |
|
| Hereditary chorea (Huntington’s) |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
226 | Thyrotrophin................ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
227 | Triamcinolone Acetonide Injection | Alopecia areata |
| Granulomata, dermal | |
|
| Keloid |
|
| Lichen planus hypertrophic |
|
| Lichen simplex chronicus |
|
| Lupus erythematosus, chronic discoid |
228 | (1) Trifluoperazine Hydrochloride, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Trifluoperazine Tablets, B.P. | Major psychoses including— |
| Major organic psychoses | |
|
| Manic psychoses |
|
| Paranoid states |
|
| Schizophrenia |
|
| Hereditary chorea (Huntington’s) |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
|
| Severe conduct disorders in patients who have not attained the age of sixteen years |
229 | Triglycerides Oil, Medium Chain | With the written authority of the Director-General, proven malabsorption |
230 | Triglyde................... | With the written authority of the Director-General, proven malabsorption |
231 | Trimethoprim with Sulphamethoxazole | Infections by organisms sensitive to Trimethoprim with Sulphamethoxazole where the infection cannot be safely and effectively treated with other sulphonamides or with any of the following administered orally— |
|
| Benzylpenicillin |
|
| Phenoxymethylpenicillin |
|
| Phenethicillin |
|
| Ocular surgery |
|
| Urinary tract infections by organisms where other sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Trimethoprim with Sulphamethoxazole |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act |
232 | Vancomycin Hydrochloride | Any disease or condition in a patient receiving treatment in or at an approved hospital |
233 | Verapamil.................. | Cardiac arrhythmias |
234 | (1) Vinblastine Sulphate | Treatment in malignant neoplasia |
| (2) Vincristine Sulphate |
|
235 | Vinyl Pyrrolidone and Vinyl Acetate with Benzocaine Aerosol Spray | Ileostomy or colostomy conditions |
236 | (1) Viomycin Sulphate | Tuberculosis |
| (2) Viomycin Sulphate Injection, B.P. |
|
237 | Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D Tablets and Capsules | Any disease or condition in a pensioner |
238 | “ ZERODOR ”.............. | Ileostomy or colostomy conditions |
239 | “ ZOFF ” .................. | Ileostomy or colostomy conditions |
|
| For use with surgical appliances |
Printed by Authority by the Government Printer of Australia